PRIMARY SCLEROSING CHOLANGITIS
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
PSC drug trial halted: A3907 safety checked in 18 adults
Disease control TerminatedThis study tested a drug called A3907 in 18 adults with Primary Sclerosing Cholangitis (PSC), a liver disease. The goal was to see if the drug is safe and tolerable. The trial was terminated early, so results are limited.
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Antibiotic trial for rare liver disease halted early
Disease control TerminatedThis study tested if the antibiotic vancomycin could safely improve liver health in adults with primary sclerosing cholangitis (PSC), a rare liver disease. About 102 participants were planned, but the trial was stopped early. The main goal was to see if vancomycin could lower alk…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2, PHASE3 • Sponsor: Elizabeth Carey • Aim: Disease control
Last updated May 22, 2026 13:51 UTC